Carol Lynch was appointed President, Sandoz US, Head of North America in March 2018. In this role, Carol leads Sandoz’ largest commercial and country organization – the United States – which is responsible for over 35 percent of Sandoz’ global revenue. Carol also oversees Sandoz’ commercial operations in Canada. She is a member of the Sandoz Executive Committee. Carol is the Vice Chair and board member of the Association for Accessible Medicines (AAM) in the US, and also serves as Chair of the Biosimilar Medicines Group, a Medicines for Europe sector group, and will continue to do so until her committ...read more